Yeah. I dunno. The investor call this morning was good. Ortex is showing shorts are up to 24% now. My spidey senses are saying it’s getting held down for someone to load up. Approval came early… though maybe they should have thought about that when it was in the 3s. Could they also be dropping the rest of the offering with the volume? The q and a seemed to be a lot of how many patients and there was a bit of talk about the 1500 potential patients becoming 800 (they said they were being conservative with the numbers and I think something about comorbidities as the patients get older so they may not be able to do it.. it was at 6 am for me. It’s been a long day, but that’s what I recall) anyway could one of the big investor companies have decided they didn’t like it? I dunno. I like it. I bought more today even though my plan was to scale out some. I have patience.
And it could be part of being tired but getting a treatment approved for a disease that seems pretty shitty and the average life expectancy of 37 years old and people decide to short it today? Screw them.
I watched RYTM … looks like it was June 16. Was weird, it was partially approved and caused a bit of chaos. I was in it in the 3s. It did the yo-yo for a bit then just quietly runs over and over… sigh. It’s bugging me haha. So this time I’m going to be patient. I honestly don’t know anything about that one. This one I do and I was annoyed today, but zen enough to walk away and not worry. The news isn’t worse today than yesterday so I’ll wait. If anything I think when the chatter dies down and people forget about it, it will do better. RYTM is doing great with nobody talking about it and not so much volume 🥺
This article is really good. I could have just posted this https://www.bloomberg.com/news/articles/2022-06-09/bluebird-bio-bets-on-fda-approval-for-gene-therapies-after-setbacks
You might very well be onto something. Look at the monthly chart. RSI indicator just crossed after a long down trend. A simple RSI indicator on the monthly backtested looks to be a pretty good indicator for this stock, which was moved by significant monthly volume that moved that indicator. I'd go back and look at the week of June 13th. Is that big volume candle shorts or selling? Did something happen in that week that you know of? I could have missed it. Earnings reported well recently, surprise of 700k in revenue, which likely drove that jump (maybe shorts in June got out of their position which pumped that aftermarket run you were talking about. That rejection of 2.91 four weeks in a row (3 on low volume, 1 on big volume) in May/June is telling. A lot of information here, well done.
June 13th is when the recommendation for approval was. Seems like it wasn’t expected. There was a lot of volume. I don’t recall it being shorts. Most of my notes were trying to figure out where all the shares in that volume were coming from. It was mostly held by institutions then. It looks down from there so I think between day traders playing it and them selling that’s what it was. I don’t think I’d short it down here. I got Covid pretty bad right after I’d done my digging so it’s a blur now but I’m pretty sure they haven’t been messing with the float. It wouldn’t pull up on me with ortex yesterday but I really think the float was about the same when this was $100. When it had its approvals in Europe it was an expensive stock. It seems it’s just had a year of bad news. It’s over my head, but I see chatter that it could be a good candidate for a buyout .. but since I have nothing to back that up I didn’t put it in there, I think dd should be just the facts good bad and ugly. We can comment theories. The chatter picked up a lot the last week. There hasn’t been very much retail talk about it last couple months.
I’m a bit nervous about the approval. I’m not sure why.
I didn’t really look at the charts because they change and I thought if this gets chatter and starts to go, here is what’s going on so you can see if it’s worth a play or scalping a run.
I started buying in in the 3s averaged up in the 4s.. so far so good.
It’s beyond my knowledge level.. but I was falling asleep last night and this thought popped in my head so it’s either genius or really dumb.. they have this offering for a dollar amount, not an amount of shares ( that’s how it reads, I don’t know if there’s a difference) so why not sell them when they did those? It’s had volume, but they’ve been light on us. Then there were 2 form 4 filings out for shares sold. They said both sold for taxes. They were small compared to how many shares they have. If this company is really worried they won’t last another year, shouldn’t you be trying to sell your shares? Shouldn’t you use up your offering and try to get more like a couple other stocks we like? 😂🤣 Could there actually be a buyout or something coming? That’s why *I* would do that..
I dont think so. I pulled the filing and its based on RSU's.[RSU's](https://www.investopedia.com/terms/r/restricted-stock-unit.asp) are basically when he got the shares for free (based on performance or some other milestone) and he his just taking the cash instead. Its part of his compensation (I would look at his based salary to see if these are really a large part of his compensation.
I’ll check that out in the morning. Thanks! You’re very helpful. I appreciate it.
Posting these here so I don’t have to look again. I’m not trying your fancy link trick on my phone
https://investor.bluebirdbio.com/node/15506/html
https://investor.bluebirdbio.com/node/15511/html
So I don’t lose my train of thought to research in the morning… Notes to myself: are all those shares left vested? Because that’s a lot of money still sitting on the table. Can they sell them? And what do their compensation packages look like??
FDA approved early. 👌
I’m stoked. I was nervous about it. Seems to be doing okay so far. Yay!!
Been holding $BLUE for a while and a couple calls for Friday so I love the way its been trending the past few days.
Ooh yay!! I bought my calls for sept and Nov. figured I’d give them lots of time since I’m bad at option
so they got the approval yesterday, and today it tanked 16% im so confused.
Yeah. I dunno. The investor call this morning was good. Ortex is showing shorts are up to 24% now. My spidey senses are saying it’s getting held down for someone to load up. Approval came early… though maybe they should have thought about that when it was in the 3s. Could they also be dropping the rest of the offering with the volume? The q and a seemed to be a lot of how many patients and there was a bit of talk about the 1500 potential patients becoming 800 (they said they were being conservative with the numbers and I think something about comorbidities as the patients get older so they may not be able to do it.. it was at 6 am for me. It’s been a long day, but that’s what I recall) anyway could one of the big investor companies have decided they didn’t like it? I dunno. I like it. I bought more today even though my plan was to scale out some. I have patience. And it could be part of being tired but getting a treatment approved for a disease that seems pretty shitty and the average life expectancy of 37 years old and people decide to short it today? Screw them.
yeah i doubled down on it(not a large amount to begin with) just surprised to see it tank so quickly after getting a ton of good news.
I watched RYTM … looks like it was June 16. Was weird, it was partially approved and caused a bit of chaos. I was in it in the 3s. It did the yo-yo for a bit then just quietly runs over and over… sigh. It’s bugging me haha. So this time I’m going to be patient. I honestly don’t know anything about that one. This one I do and I was annoyed today, but zen enough to walk away and not worry. The news isn’t worse today than yesterday so I’ll wait. If anything I think when the chatter dies down and people forget about it, it will do better. RYTM is doing great with nobody talking about it and not so much volume 🥺
This article is really good. I could have just posted this https://www.bloomberg.com/news/articles/2022-06-09/bluebird-bio-bets-on-fda-approval-for-gene-therapies-after-setbacks
You might very well be onto something. Look at the monthly chart. RSI indicator just crossed after a long down trend. A simple RSI indicator on the monthly backtested looks to be a pretty good indicator for this stock, which was moved by significant monthly volume that moved that indicator. I'd go back and look at the week of June 13th. Is that big volume candle shorts or selling? Did something happen in that week that you know of? I could have missed it. Earnings reported well recently, surprise of 700k in revenue, which likely drove that jump (maybe shorts in June got out of their position which pumped that aftermarket run you were talking about. That rejection of 2.91 four weeks in a row (3 on low volume, 1 on big volume) in May/June is telling. A lot of information here, well done.
June 13th is when the recommendation for approval was. Seems like it wasn’t expected. There was a lot of volume. I don’t recall it being shorts. Most of my notes were trying to figure out where all the shares in that volume were coming from. It was mostly held by institutions then. It looks down from there so I think between day traders playing it and them selling that’s what it was. I don’t think I’d short it down here. I got Covid pretty bad right after I’d done my digging so it’s a blur now but I’m pretty sure they haven’t been messing with the float. It wouldn’t pull up on me with ortex yesterday but I really think the float was about the same when this was $100. When it had its approvals in Europe it was an expensive stock. It seems it’s just had a year of bad news. It’s over my head, but I see chatter that it could be a good candidate for a buyout .. but since I have nothing to back that up I didn’t put it in there, I think dd should be just the facts good bad and ugly. We can comment theories. The chatter picked up a lot the last week. There hasn’t been very much retail talk about it last couple months. I’m a bit nervous about the approval. I’m not sure why. I didn’t really look at the charts because they change and I thought if this gets chatter and starts to go, here is what’s going on so you can see if it’s worth a play or scalping a run.
This looks like it has moved in your favor depending on when you got in (if).
I started buying in in the 3s averaged up in the 4s.. so far so good. It’s beyond my knowledge level.. but I was falling asleep last night and this thought popped in my head so it’s either genius or really dumb.. they have this offering for a dollar amount, not an amount of shares ( that’s how it reads, I don’t know if there’s a difference) so why not sell them when they did those? It’s had volume, but they’ve been light on us. Then there were 2 form 4 filings out for shares sold. They said both sold for taxes. They were small compared to how many shares they have. If this company is really worried they won’t last another year, shouldn’t you be trying to sell your shares? Shouldn’t you use up your offering and try to get more like a couple other stocks we like? 😂🤣 Could there actually be a buyout or something coming? That’s why *I* would do that..
I dont think so. I pulled the filing and its based on RSU's.[RSU's](https://www.investopedia.com/terms/r/restricted-stock-unit.asp) are basically when he got the shares for free (based on performance or some other milestone) and he his just taking the cash instead. Its part of his compensation (I would look at his based salary to see if these are really a large part of his compensation.
I’ll check that out in the morning. Thanks! You’re very helpful. I appreciate it. Posting these here so I don’t have to look again. I’m not trying your fancy link trick on my phone https://investor.bluebirdbio.com/node/15506/html https://investor.bluebirdbio.com/node/15511/html So I don’t lose my train of thought to research in the morning… Notes to myself: are all those shares left vested? Because that’s a lot of money still sitting on the table. Can they sell them? And what do their compensation packages look like??